Pure Global

Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular Recovery in SCI - Trial NCT06313515

Access comprehensive clinical trial information for NCT06313515 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Washington and is currently Recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06313515
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06313515
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular Recovery in SCI
Transcutaneous Spinal Cord Stimulation Combined With Arm Crank Exercise for Cardiovascular Recovery in Cervical and Upper Thoracic SCI

Study Focus

Spinal Cord Injuries

Transcutaneous Spinal Cord Stimulation

Interventional

device

Sponsor & Location

University of Washington

Seattle, United States of America

Timeline & Enrollment

N/A

Apr 01, 2024

Feb 01, 2027

16 participants

Primary Outcome

Change in systolic Blood Pressure (BP) from baseline.,Change in systolic Blood Pressure during a sit-up test or head-up tilt test.,Heart rate variability recorded by electrocardiogram (ECG).

Summary

Spinal cord injury (SCI) can make it hard for the body to self-regulate some of its automatic
 functions like blood pressure, breathing, and heart rate. This can also make it hard for
 those living with SCI to exercise or complete their usual daily activities. The goal of this
 randomized trial is to test combinatory therapy of moderate arm-crank exercise paired with
 non-invasive transcutaneous spinal cord stimulation (tSCS) for cardiovascular recovery in
 adults aged 21-65 following chronic motor-complete spinal cord injury (SCI) at or above the
 thoracic sixth spinal segment (โ‰ฅT6).
 
 The main questions the study aims to answer are:
 
 - Conduct tSCS mapping to determine the most effective location and stimulation intensity
 for BP control in individuals with motor-complete SCI โ‰ฅ T6.
 
 - Evaluate the effects 8 weeks of targeted tSCS paired with arm-crank exercise compared to
 sham stimulation with exercise on improving cardiovascular function in individuals with
 motor-complete SCI โ‰ฅT6.
 
 - Evaluate the dosage-response of 8 weeks vs. 16 weeks of targeted tSCS paired with
 arm-crank exercise on cardiovascular function in individuals with motor-complete SCI
 โ‰ฅT6.
 
 - Explore the mechanisms involved in cardiovascular recovery with long-term tSCS paired
 with arm-crank exercise.
 
 Participants will:
 
 - Receive either transcutaneous spinal cord stimulation or sham spinal cord stimulation
 while exercising on an arm-crank bicycle in the first 8 weeks.
 
 - Come in for approximately 60 visits over a 6-month period. This includes 2, 8-week
 periods where the investigators will ask participants to come in 3x per week for spinal
 cord stimulation and exercise.
 
 - During assessment visits the researchers will perform a variety of exams including a
 neurologic, cardiovascular, pulmonary, physical, and autonomic exam, and will ask
 questions about quality of life and functioning.
 
 Researchers will compare those who receive tSCS and do moderate arm-crank exercise to those
 who receive a sham stimulation and do moderate arm-crank exercise to see if tSCS is effective
 at improving cardiovascular and autonomic functioning in those with SCI.

ICD-10 Classifications

Sequelae of injury of spinal cord
Other and unspecified injuries of thoracic spinal cord
Other and unspecified injuries of cervical spinal cord
Other injury of lumbar spinal cord
Injury of spinal cord, level unspecified

Data Source

ClinicalTrials.gov

NCT06313515

Device Trial